Results 151 to 160 of about 2,401,578 (298)
The Human Biomarker Navigator integrates the disease continuum, biomarker dynamics, cross‐organ biomarker networks, biomarker classification, and technology‐driven paradigms. It maps how biomarkers link multi‐system physiology and pathology across the nervous, respiratory, endocrine, circulatory, immune, digestive, urinary, reproductive, and ...
Meng‐Yao Li +29 more
wiley +1 more source
National Intelligence Daily (Cable) 13 March 1982 [PDF]
Declassified on 2017-11 ...
United States. Central Intelligence Agency.
core
National Intelligence Daily (Cable) 7 April 1982 [PDF]
Declassified on 2017-11 ...
United States. Central Intelligence Agency.
core
Multi‐omics–driven precision medicine
Multi‐omics‐driven precision medicine (MODPM) provides a multiscale, continuously learnable framework that integrates genomics, epigenomics, transcriptomics, proteomics, metabolomics, microbiome profiles, and clinical data. Powered by artificial intelligence and foundation models, MODPM enables cross‐modal representation learning, contextual modeling ...
Huibo Li +20 more
wiley +1 more source
National Intelligence Daily (Cable) 26 August 1982 [PDF]
Declassified on 2017-11 ...
United States. Central Intelligence Agency.
core
ABSTRACT Ovarian cancer (OC) continues to be the deadliest gynecological malignancy and a significant cause of cancer‐related mortality among women worldwide. Standard treatment strategies typically entail platinum‐based chemotherapy in conjunction with cytoreductive surgery.
Zunera Khalid +4 more
wiley +1 more source
Brain organoid implications have opened vast avenues in the realm of interdisciplinary research, particularly in the growing field of organoid intelligence (OI). A brain organoid is a three-dimensional (3D), lab-grown structure that mimics certain aspects of the human brain organization and function.
Sangeeta Ballav +3 more
openaire +1 more source
Natural products and traditional Chinese medicine target metabolic pathways underlying right ventricular dysfunction in pulmonary arterial hypertension. Integrating multi‐omics, artificial intelligence, and systems biology may enable precision cardiometabolic therapies to restore right ventricular metabolism and improve clinical outcomes.
Yihao Wu, Zhehui Tang, Hongwei Yao
wiley +1 more source
National Intelligence Daily 5 January 1980 [PDF]
Declassified on 2017-11 ...
United States. Central Intelligence Agency.
core
ABSTRACT It is estimated that a large proportion of drug candidates fail in human clinical trials, mainly because animal models cannot fully replicate human disease and because of differential responses to various medications between humans and animals.
Weiping Ding, Iqra Ilyas, Suowen Xu
wiley +1 more source

